CLOTRIMAZOLE

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: CLOTRIMAZOLE
Generic name: CLOTRIMAZOLE
Manufacturer: GRAXCELL PHARMACEUTICAL, LLC.
Product type: HUMAN OTC DRUG
SPL set ID: 5f8ca6ad-cb25-1abf-e053-2a91aa0aca99
SPL ID: 46d03d44-41ab-379e-e063-6394a90ab45d
Version: 15
Effective date: 2025-12-25
Source export date: 2026-09-28
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:38:34

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		CLOTRIMAZOLE	openfda.brand_name
generic name		CLOTRIMAZOLE	openfda.generic_name
manufacturer name		GRAXCELL PHARMACEUTICAL, LLC.	openfda.manufacturer_name
ndc	package	70795-8020-1	openfda.package_ndc
ndc	product	70795-8020	openfda.product_ndc
ndc11	package	70795802001	derived:openfda.package_ndc
spl id		46d03d44-41ab-379e-e063-6394a90ab45d	id
spl set id		5f8ca6ad-cb25-1abf-e053-2a91aa0aca99	set_id
unii		G07GZ97H65	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

warnings For external use only Ask a doctor before use on children under 2 years of age When using this product avoid contact with eyes Stop use and ask a doctor if irritation occurs there is no improvement within 4 weeks (for athlete's foot and ringworm) or 2 weeks (for jock itch)

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.